0M4.F - Mersana Therapeutics, Inc.

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Show:
Balance Sheet
Cash Flow
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

Currency in USD. All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Breakdown
ttm
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Total Revenue
26,581
26,581
43
828
42,123
Operating Expense
230,348
230,348
168,901
88,938
72,323
Operating Income
-203,767
-203,767
-168,858
-88,110
-30,200
Net Non Operating Interest Income Expense
-445
-445
-1,202
65
1,992
Other Income Expense
-
-445
-1,202
-
-
Pretax Income
-204,212
-204,212
-170,060
-88,045
-28,208
Net Income Common Stockholders
-204,212
-204,212
-170,060
-88,045
-28,208
Diluted NI Available to Com Stockholders
-204,212
-204,212
-170,060
-88,045
-28,208
Basic EPS
-
-2.18
-2.41
-1.43
-0.65
Diluted EPS
-
-2.18
-2.41
-1.43
-0.65
Basic Average Shares
-
93,654
70,581
61,485
43,492
Diluted Average Shares
-
93,654
70,581
61,485
43,492
Total Expenses
230,348
230,348
168,901
88,938
72,323
Net Income from Continuing & Discontinued Operation
-204,212
-204,212
-170,060
-88,045
-28,208
Normalized Income
-204,212
-204,212
-170,060
-88,045
-28,208
Interest Income
2,883
2,883
65
424
2,226
Interest Expense
3,328
3,328
1,267
359
234
Net Interest Income
-445
-445
-1,202
65
1,992
EBIT
-200,884
-203,767
-168,858
-87,686
-27,974
EBITDA
-199,957
-
-
-
-
Reconciled Depreciation
927
927
855
1,010
1,245
Net Income from Continuing Operation Net Minority Interest
-204,212
-204,212
-170,060
-88,045
-28,208
Normalized EBITDA
-199,957
-203,767
-168,858
-86,676
-27,974
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0

Yahoo Finance Plus Essential access required.

Learn more